Comparison

Cardiotoxin Analog (CTX) IV (6-12) TFA European Partner

Item no. TMO-TP1289-25mg
Manufacturer TargetMol
CASRN 2918768-05-3
Amount 25 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 100.00%
Citations Kaneda N, et al. The amino acid sequence of cardiotoxin-analogue IV from the venom of Naja naja atra. FEBS Lett. 1976 Nov;70(1):217-22.
Smiles CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CNC5=CC=CC=C54)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CC(C)C)N.C(=O)(C(F)(F)F)O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Cardiotoxin Analog (CTX) IV (6-12) (TFA)(115722-23-1,FREE)
Shipping condition Cool pack
Available
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
1013, 16
Target names or alias
Cardiotoxin Analog (CTX) IV (6-12) (TFA)(115722-23-1, FREE)
Description
Cardiotoxin Analog IV (6-12) TFA, a partial peptide of Cardiotoxin Analog IV, is derived from the venom of the Taiwan Cobra, showcasing the unique properties of snake venom cardiotoxin[1].
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close